ANDA 202691, held by Hikma Pharmaceuticals. Methylprednisolone Sodium Succinate.
As of Nov 21, 2026, ANDA 202691 (Methylprednisolone Sodium Succinate), held by Hikma Pharmaceuticals, was first approved by FDA on Feb 16, 2016, with 4 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of Methylprednisolone Sodium Succinate for Injection, USP, is indicated as follows: Allergic states Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 16, 2016 | Original application | Approved | None posted |
| Methylprednisolone Sodium SuccinateEQ 500MG BASE/VIAL · injectable;injection | Methylprednisolone Sodium Succinate | Rx |
| Methylprednisolone Sodium SuccinateEQ 1GM BASE/VIAL · injectable;injection | Methylprednisolone Sodium Succinate | Rx |
| Jun 11, 2026 | Supplement 9Labeling · Standard review | Approved | None posted |
| Dec 19, 2024 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 23, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Dec 23, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 16, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters